Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L01F" (5)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Monoclonal Antibodies and Antibody Drug Conjugates (L01F) 1 products
WHO-DDD
L
IP
Elrexfio 76 mg/1.9 ml
4938.32
5374.50
10 %
Injection solution: Elranatamabum 76mg / 1.9ml
Pfizer AG
A / SL
FB
G
Other Monoclonal Antibodies and Antibody Drug Conjugates (L01FX) 4 products
WHO-DDD
L
IP
Talvey 40 mg/1.0 ml
4310.67
4704.55
10 %
Injection solution: Talquetamabum 40 mg/ml
Janssen-Cilag AG
A / SL
FB
G
IP
Columvi 10 mg/10 ml
k.A.
Concentrate for infusion: Glofitamabum 10mg / 10ml
Roche Pharma
(Schweiz) AG
A
FB
G
IP
Vyloy 100 mg
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Zolbetuximabum 100 mg
Astellas Pharma AG
A
FB
G
IP
Vyloy 100 mg
3
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Zolbetuximabum 100 mg
Astellas Pharma AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home